======= HUWE1 ======= == Gene Information == * **Official Symbol**: HUWE1 * **Official Name**: HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10075|10075]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q7Z6Z7|Q7Z6Z7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HUWE1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HUWE1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300697|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein containing a C-terminal HECT (E6AP type E3 ubiquitin protein ligase) domain that functions as an E3 ubiquitin ligase. The encoded protein is required for the ubiquitination and subsequent degradation of the anti-apoptotic protein Mcl1 (myeloid cell leukemia sequence 1 (BCL2-related)). This protein also ubiquitinates the p53 tumor suppressor, core histones, and DNA polymerase beta. Mutations in this gene are associated with Turner type X-linked syndromic cognitive disability. [provided by RefSeq, Aug 2013]. * **UniProt Summary**: N/A |HECT| |WWE| |UBA| |DUF908| |DUF913| |positive regulation of protein targeting to mitochondrion| |base-excision repair| |histone ubiquitination| |regulation of protein targeting to mitochondrion| |positive regulation of establishment of protein localization to mitochondrion| |protein monoubiquitination| |circadian regulation of gene expression| |regulation of establishment of protein localization to mitochondrion| |regulation of protein targeting| |positive regulation of protein ubiquitination| |positive regulation of mitochondrion organization| |secretory granule lumen| |ficolin-1-rich granule lumen| |positive regulation of protein modification by small protein conjugation or removal| |circadian rhythm| |positive regulation of intracellular protein transport| |regulation of mitochondrion organization| |regulation of protein ubiquitination| |positive regulation of intracellular transport| |ubiquitin protein ligase activity| |regulation of protein modification by small protein conjugation or removal| |regulation of intracellular protein transport| |ubiquitin-protein transferase activity| |rhythmic process| |protein polyubiquitination| |positive regulation of cellular protein localization| |regulation of intracellular transport| |histone modification| |covalent chromatin modification| |positive regulation of protein transport| |positive regulation of establishment of protein localization| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |DNA repair| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |regulation of cellular protein localization| |modification-dependent macromolecule catabolic process| |myeloid leukocyte activation| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |positive regulation of organelle organization| |leukocyte activation involved in immune response| |cell activation involved in immune response| |protein catabolic process| |protein ubiquitination| |chromatin organization| |regulated exocytosis| |regulation of protein transport| |regulation of peptide transport| |DNA metabolic process| |regulation of establishment of protein localization| |leukocyte mediated immunity| |protein modification by small protein conjugation| |cellular response to DNA damage stimulus| |exocytosis| |cellular macromolecule catabolic process| |regulation of cellular localization| |leukocyte activation| |protein modification by small protein conjugation or removal| |positive regulation of transport| |secretion by cell| |regulation of protein localization| |export from cell| |macromolecule catabolic process| |organonitrogen compound catabolic process| |chromosome organization| |cell activation| |immune effector process| |secretion| |positive regulation of cellular component organization| |positive regulation of protein modification process| |proteolysis| |regulation of organelle organization| |RNA binding| |DNA binding| |positive regulation of cellular protein metabolic process| |cellular response to stress| |positive regulation of protein metabolic process| |organic substance catabolic process| |cellular catabolic process| |regulation of protein modification process| |regulation of transport| |immune response| |extracellular region| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp531|THZ1 0.06μM R08 exp531]]|1.91| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 524/683 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|19/28| |blood|24/26| |bone|18/25| |breast|22/30| |central nervous system|36/49| |cervix|2/4| |colorectal|14/17| |esophagus|11/11| |fibroblast|1/1| |gastric|9/14| |kidney|18/18| |liver|12/19| |lung|53/72| |lymphocyte|10/14| |ovary|18/25| |pancreas|18/22| |peripheral nervous system|12/15| |plasma cell|10/12| |prostate|1/1| |skin|17/20| |soft tissue|5/7| |thyroid|2/2| |upper aerodigestive|19/22| |urinary tract|17/28| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 573 * **Expression level (log2 read counts)**: 9.27 {{:chemogenomics:nalm6 dist.png?nolink |}}